MarketPeel
Insider Trading Intelligence
JR

Jeffrey A. Rona

OVID
CHIEF BUSINESS OFFICER · OVID THERAPEUTICS INC. · CIK 0001311404
FILING MIX · LIFETIME88%/12%
BUYS
15
SELLS
2
TOTAL VALUE
$14.6K
COMPANIES
1
ACTIVE SINCE
Sep 2020
HOLDINGS NOW
156,313
AVG SELL PX
$1.17
TRADE KIND
SHOWING 17 / 17
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 4 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Jeffrey A. Rona, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+50.00%+3.96%-0.67%+4.63%+4.63%
14d2+50.00%+20.29%-3.30%+23.59%+23.59%
30d2+50.00%+15.30%-5.00%+20.31%+20.31%
60d2+50.00%+22.20%-1.22%+23.42%+23.42%
90d2+50.00%+12.23%-0.27%-45.61%-45.61%
180d2(1 pending)+0.00%+112.01%+8.39%+103.63%+103.63%
1y2(1 pending)+0.00%+206.86%+16.29%+190.57%+190.57%
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
OVID · 156,313 shares · as of Feb 26, 2026
0102,188204,375306,563408,750202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 15 buys / 2 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
OVID
OVID THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
408,750408,750Feb 26, 2026Mar 2, 2026View →
OVID
OVID THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
68,125156,313Feb 26, 2026Mar 2, 2026View →
OVID
OVID THERAPEUTICS INC.
SALE
CBFO
8,541$1.45$12.4K88,188Feb 23, 2026Mar 2, 2026View →
OVID
OVID THERAPEUTICS INC.
SALE
CBFO
3,902$0.56$2.2K67,973Feb 26, 2025Feb 28, 2025View →
OVID
OVID THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
262,500262,500Feb 20, 2025Feb 24, 2025View →
OVID
OVID THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
43,75071,875Feb 20, 2025Feb 24, 2025View →
OVID
OVID THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
315,000315,000Jul 30, 2024Aug 1, 2024View →
OVID
OVID THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
28,12528,125Feb 22, 2024Feb 26, 2024View →
OVID
OVID THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
168,7500Feb 22, 2024Feb 26, 2024View →
OVID
OVID THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
175,000175,000Feb 23, 2023Feb 27, 2023View →
OVID
OVID THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
10,00010,000Apr 8, 2022Apr 12, 2022View →
OVID
OVID THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
194,399194,399Apr 8, 2022Apr 12, 2022View →
OVID
OVID THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
218,750218,750Feb 3, 2022Feb 4, 2022View →
OVID
OVID THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
100,000100,000Jun 2, 2021Jun 10, 2021View →
OVID
OVID THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
175,000175,000Dec 17, 2020Dec 21, 2020View →
OVID
OVID THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
20,00020,000Oct 11, 2020Oct 13, 2020View →
OVID
OVID THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
325,000325,000Sep 30, 2020Oct 2, 2020View →
Other insiders · OVID
Loading peer insiders…
About this filer
CIK 0001311404
ROLE
Chief Business Officer
PRIMARY
OVID
COMPANIES
1
ACTIVE SINCE
Sep 2020
MARKETPEEL · /INSIDER/0001311404DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback